Notably, even in the absence of BCMA expression, U15BCAR-NKT and Allo15BCAR-NKT cells maintained potent, dose-dependent tumor clearance, underscoring their superior adaptability in targeting malignant cells (Figures 5A and 5B). The gene discussed is TNFRSF17; the disease is neoplasm.